Latest Shareholder Update, 1 Feb 08
...Welcome to this second edition of MTY News...
Clinical collaboration agreement signed, 4 Jun 07
....for up to three GI indications....
Positive Clinical Interim Results
...completed its ‘first-in-human’ clinical trial...
Feature Article - Australian Investor Magazine
...making dramatic moves with new CEO...
Commencing Human Clinical Trials of Cuprindo™
...clinical trials of Cuprindo™ to determine its safety...
Sucessful Settlement of Dispute
...MTY successfully settled its dispute with The University of Sydney...


Medical Therapies Ltd
(MTY):


Medical Therapies Limited (MTY) is an Australian pharmaceutical development company committed to the commercialisation of its drug candidates for a range of anti-inflammatory conditions.

Medical Therapies' focus is to reformulate or re-profile existing drugs and prove these new candidates up for therapeutic use by demonstrating improved safety and/or efficacy in certain conditions.


2007 Medical Therapies Ltd Annual Report
   View Interactive 2007 Annual Report


Join our Mailing List

We invite you to receive our news electronically


Interested in Investing?

Download our latest investor presentation .pdf

Play audio investor presentation by Maria Halasz, MD & CEO    





                                                                             

© Medical Therapies
Web design company
Medical Therapies Ltd   ABN 69 111 304 119   T: +61 2 9299 0311   E: info@medicaltherapies.com.au